Abstract:Suppressor of cytokine signaling 3 (SOCS3), a negative regulator of cytokine signaling, is expressed in breast cancer cells where it can modify sensitivity and responsiveness to cytokine signaling through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathways. Although it is widely accepted that SOCS3 expression is in itself regulated by STATs, we and others have shown that prostaglandins can also up-regulate SOCS3 expression. Here we used T47D breast cancer cells treated with prostaglandin E2 (PGE2) to examine this pathway. T47D cells responded to PGE2 stimulation with a significant increase in SOCS3 mRNA that was independent of de novo protein synthesis. PGE2 stimulation resulted in STAT3 serine and tyrosine phosphorylation, although mutation of either of the two previously characterized STAT response elements on the SOCS3 promoter did not affect SOCS3 promoter activation by PGE2. In addition, overexpression of STAT3 wild-type, constitutively active or dominant-negative constructs did not affect PGE2-induced SOCS3 promoter activation, indicating that STATs are unlikely mediators of this pathway in these cells. PGE2 is a known activator of the cAMP/protein kinase A (PKA) pathway, and in T47D cells, up-regulation of SOCS3 mRNA by PGE2 was abolished by pretreatment with H89, a PKA inhibitor and increased by cAMP and forskolin treatment. Consistent with this, PGE2 treatment increased cAMP response element (CRE)-binding protein serine phosphorylation. However, mutation of the activator protein 1/CRE on the promoter did not affect basal or PGE2-stimulated activation, suggesting a role for cAMP/PKA that is independent of CRE-binding protein binding. Mutation of the GC-rich region of the SOCS3 promoter, a putative Sp1/Sp3 binding site, abolished both basal and PGE2-stimulated activation. Gel-shift assays showed increased complex formation after treatment, and this was inhibited by the addition of an Sp1 antibody or pretreatment with PKA inhibitor. Chromatin immunoprecipitation assay verified Sp1 binding to the promoter in response to PGE2. Sp1 overexpression increased SOCS3 promoter activation, and both basal and PGE2-induced SOCS3 mRNA expression was prevented by mithramycin, an inhibitor of Sp1 DNA binding. Finally, a physiological role for PGE2 was demonstrated with PGE2 pretreatment reducing lipopolysaccharide-induced STAT3 activation. Collectively, this study details a novel mechanism of SOCS3 up-regulation by PGE2 in breast cancer cells that appears to be STAT independent and involve Sp1 binding to the promoter. This process has possible implications for cytokine responsiveness and tumor progression.

Specificity of transcription enhancement via the STAT responsive element in the serine protease inhibitor 2.1 promoter

Abstract 5511: Lineage-specific and Shared Cytokine-Sensing Genes Respond Distinctly to the Master Regulator STAT5

Lineage-Specific and Non-specific Cytokine-Sensing Genes Respond Differentially to the Master Regulator STAT5

Growth Hormone Specifically Regulates Serine Protease Inhibitor Gene Transcription Via Gamma-Activated Sequence-Like DNA Elements.

An Autoregulatory Enhancer Controls Mammary-Specific Stat5 Functions

Mediation of Growth Hormone-dependent Transcriptional Activation by Mammary Gland Factor/Stat 5

Extracellular signal-regulated kinase (ERK) interacts with signal transducer and activator of transcription (STAT) 5a

The Growth Hormone-binding Protein is a Location-dependent Cytokine Receptor Transcriptional Enhancer

Regulation of Suppressor of Cytokine Signaling 3 (SOC3) by Growth Hormone in Pro-B Cells

Expression of Constitutively Active Gs Alpha-Subunits in GH3 Pituitary Cells Stimulates Prolactin Promoter Activity.

Identification of the Camp Response Element That Controls Transcriptional Activation of the Insulin-like Growth Factor-I Gene by Prostaglandin E2 in Osteoblasts

Characterization of the SOCS3 Promoter Response to Prostaglandin E2 in T47D Cells

Stat1 Regulates Human Glutaminase 1 Promoter Activity Through Multiple Binding Sites In Hiv-1 Infected Macrophages

Regulation of Socs Gene Expression by the Proto-oncoprotein GFI-1B: TWO ROUTES FOR STAT5 TARGET GENE INDUCTION BY ERYTHROPOIETIN

Defining the epigenetic actions of growth hormone: acute chromatin changes accompany GH-activated gene transcription

Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580

Growth Hormone-Induced Reorganization of the Actin Cytoskeleton is Not Required for STAT5 (signal Transducer and Activator of Transcription-5)-mediated Transcription.

Stat5-Mediated Chromatin Interactions In Superenhancers Activate Il-2 Highly Inducible Genes: Functional Dissection Of The Il2ra Gene Locus

Inhaled Treprostinil after Initial Clinical Worsening: to Continue or Not to Continue, That’s the Question

Two Tandemly Linked Interferon-Gamma-Activated Sequence Elements in the Promoter of Glycosylation-Dependent Cell Adhesion Molecule 1 Gene Synergistically Respond to Prolactin in Mouse Mammary Epithelial Cells

Stat5a Regulates the Glcnac-1-Phosphate Transferase Gene Transcription and Expression